[HTML][HTML] The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV
H Akamatsu, K Ninomiya, H Kenmotsu… - International journal of …, 2019 - Springer
According to rapid development of chemotherapy in advanced non-small cell lung cancer
(NSCLC), the Japan Lung Cancer Society has been updated its own guideline annually …
(NSCLC), the Japan Lung Cancer Society has been updated its own guideline annually …
Clinical outcomes of different generations of EGFR tyrosine kinase inhibitors in advanced lung adenosquamous carcinoma
M Hu, B Zhang, J Xu, S Wang, Y Zhao, L Zhang… - Molecular Diagnosis & …, 2019 - Springer
Objectives The role of targeted therapy in patients with lung adenosquamous carcinoma
(ASC) has been controversial and it was unclear whether a third-generation epidermal …
(ASC) has been controversial and it was unclear whether a third-generation epidermal …
Clinicopathological Characteristics And EGFR-TKIs Efficacies In Lung Squamous Cell Carcinoma Patients Harboring An EGFR Sensitizing Mutation
S Zhou, H Wang, W Jiang, Q Yu - OncoTargets and therapy, 2019 - Taylor & Francis
Objective This study analyzed the relationship between the clinicopathological features and
epidermal growth factor receptor (EGFR) mutation status of squamous cell lung cancer …
epidermal growth factor receptor (EGFR) mutation status of squamous cell lung cancer …
[HTML][HTML] A proposal to reflect survival difference and modify the staging system for lung adenocarcinoma and squamous cell carcinoma: based on the machine …
M Li, C Zhan, X Sui, W Jiang, Y Shi, X Yang… - Frontiers in …, 2019 - frontiersin.org
Objective: To propose modifications to refine prognostication over anatomic extent of the
current tumor, node, and metastasis (TNM) staging system of non-small cell lung cancer …
current tumor, node, and metastasis (TNM) staging system of non-small cell lung cancer …
[HTML][HTML] Analysis of real-word mutations of lung cancer driver genes in five regions of China
M Sun, Y Guo, G Shao, X Duan, Z Yang… - Translational Cancer …, 2019 - ncbi.nlm.nih.gov
Background The aim of this study was to analyse the epidemiological characteristics and
clinical features of the three driver genes EGFR, ALK and ROS1 in Chinese patients with …
clinical features of the three driver genes EGFR, ALK and ROS1 in Chinese patients with …
High-throughput RNAi screen identifies ILK as a target to overcome intrinsic EGFR-TKI resistance of lung squamous carcinoma
L Ju, Z Dong, J Yang, J Li, R Ren - 2019 - researchsquare.com
Although targeted therapy has made a significant efficacy in lung adenocarcinoma, there are
still no effective targeted drugs for lung squamous cell carcinoma (SqCC). Moreover …
still no effective targeted drugs for lung squamous cell carcinoma (SqCC). Moreover …